FDA Grants TA for Viloxazine Hydrochloride Application ANDA220326
The FDA has granted Tentative Approval (TA) for Viloxazine Hydrochloride under application ANDA220326 submitted by Appco Pharma LLC.
Company
Pharmaceutical intelligence for Appco Pharma LLC with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.